// App-Quantinova.ai

: Anticoagulation in Cancer Patients with Atrial Fibrillation and Grade 3-4 Thrombocytopenia

Researchers

Presenter

  • Genady Drozdinsky

Principal Investigators

  • Noam Arad

  • Galia Spectre

  • Nir Livneh

  • Itamar Poran

  • Pia Raanani

  • Anna Falanga

  • Hugo ten Cate

  • Anat Gafter-Gvili

  • Avi Leader

Medical Centers

  • Thrombosis Expert Center, Maastricht University Medical Center, and Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, Netherlands

  • Department of Medicine, and Immunohematology and Transfusion Medicine Department, University of Milan Bicocca, Hospital Papa Giovanni XXIII, Bergamo, Italy

  • Department of Otolaryngology Head and Neck Surgery, Sheba Medical Center, Tel Hashomer, Israel

  • Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah -Tikva, Israel

  • Department of Medicine A, Rabin medical center, Beilinson hospital, Petah Tikva, Israel

  • Department of medicine E, Rabin medical center, Beilinson Hospital, Petah Tikva, Israel

  • Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

  • Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Locations

  • Netherlands

  • Israel

  • Italy

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Transient Ischemic Attack

  • Arrhythmia

  • Thrombocytopenia

  • Ischemic stroke

  • Venous thrombosis

  • Acute Leukemia

  • Solid malignancies

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved